Nexium Buyers Say 3rd Circ.'s Lamictal Ruling Backs New Trial
Plaintiffs in the Nexium pay-for-delay antitrust class action urged a Massachusetts federal court to grant them a new trial Monday because of the Third Circuit's recent Lamictal ruling that reverse payments...To view the full article, register now.
Already a subscriber? Click here to view full article